AYA · ASX

Artrya Limited (ASX:AYA)

AU$0.68

 0.045 (7.143%)
ASX:Live
09/05/2025 03:49:01 PM
Hammer Bullish HALO Ords HALO Momentum GROWTH AUS All-Consensus +1
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

AYA Overview

AYA Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Neutral

Earnings

Weak

Growth

Earnings

Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About AYA

Website

N/A

Telephone

61.8.6478.7816

Address

1257 Hay Street West Perth, Western Australia (WA) 6005

Description

Artrya Ltd. develops the Salix suite of products to address coronary artery disease (CAD). It uses artificial intelligence (AI) to improve the detection and management of coronary artery disease. The company was founded by John Windsor Barrington and John Konstantopoulos on January 24, 2018 and is headquartered in West Perth, Australia.

AYA Price Chart

Key Stats

Market Cap

AU$71.10M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.2 - 1.04

Trade Value (12mth)

AU$20,220.00

1 week

-5.26%

1 month

8.62%

YTD

1.61%

1 year

103.23%

All time high

1.75

Key Fundamentals

EPS 3 yr Growth

241.00%

EBITDA Margin

N/A

Operating Cashflow

-$15m

Free Cash Flow Return

-61.10%

ROIC

-57.20%

Interest Coverage

-517.80

Quick Ratio

7.30

Other Data

Shares on Issue (Fully Dilluted)

82m

HALO Sector

Technology

Next Company Report Date

28-Aug-25

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

AYA Announcements

Latest Announcements

Date Announcements

05 May 25

Application for quotation of securities - AYA

×

Application for quotation of securities - AYA

05 May 25

Cleansing Statement

×

Cleansing Statement

01 May 25

Artrya Quarterly Call Presentation

×

Artrya Quarterly Call Presentation

30 April 25

Notification of cessation of securities - AYA

×

Notification of cessation of securities - AYA

28 April 25

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

08 April 25

Completion of Placement and Cleansing Notice

×

Completion of Placement and Cleansing Notice

08 April 25

Application for quotation of securities - AYA

×

Application for quotation of securities - AYA

08 April 25

Notification regarding unquoted securities - AYA

×

Notification regarding unquoted securities - AYA

02 April 25

Results of Meeting

×

Results of Meeting

01 April 25

Artrya Secures Contract with Lumas Imaging

×

Artrya Secures Contract with Lumas Imaging

01 April 25

Issue of Shares on Exercise of Performance Rights

×

Issue of Shares on Exercise of Performance Rights

01 April 25

Application for quotation of securities - AYA

×

Application for quotation of securities - AYA

31 March 25

Investor Webinar Presentation

×

Investor Webinar Presentation

28 March 25

Artrya Secures FDA Clearance for Salix Coronary Anatomy

×

Artrya Secures FDA Clearance for Salix Coronary Anatomy

24 March 25

Issue of Shares on Exercise of Performance Rights

×

Issue of Shares on Exercise of Performance Rights

24 March 25

Application for quotation of securities - AYA

×

Application for quotation of securities - AYA

12 March 25

Issue of Shares on Exercise of Performance Rights

×

Issue of Shares on Exercise of Performance Rights

12 March 25

Application for quotation of securities - AYA

×

Application for quotation of securities - AYA

28 February 25

Artrya Provides Update on US FDA Application

×

Artrya Provides Update on US FDA Application

28 February 25

Notice of General Meeting & Proxy Form

×

Notice of General Meeting & Proxy Form

28 February 25

Issue of Shares on Exercise of Performance Rights

×

Issue of Shares on Exercise of Performance Rights

28 February 25

Application for quotation of securities - AYA

×

Application for quotation of securities - AYA

25 February 25

Appendix 4D and Interim Financial Report

×

Appendix 4D and Interim Financial Report

25 February 25

Issue of Shares on Exercise of Performance Rights

×

Issue of Shares on Exercise of Performance Rights

25 February 25

Application for quotation of securities - AYA

×

Application for quotation of securities - AYA

AYA Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.26 -0.14 -0.18 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.26 -0.14 -0.18 Lock Lock Lock
     Growth % Lock Lock Lock Lock -396.6 45.2 -25.3 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.14 -0.13 -0.20 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.17 -0.14 -0.19 Lock Lock Lock
     Growth % Lock Lock Lock Lock -299.6 4.4 -45.9 Lock Lock Lock
     Yield % Lock Lock Lock Lock -26.7 -64.0 -86.7 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.52 0.39 0.21 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.47 0.30 0.14 Lock Lock Lock
     Growth % Lock Lock Lock Lock 175.6 -37.0 -52.7 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 66 78 79 Lock Lock Lock
Basic m Lock Lock Lock Lock 66 78 79 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Income Statement
Sales $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 17 12 16 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 0 -1 -2 Lock Lock Lock
     Growth % Lock Lock Lock Lock -424.5 -173.3 -261.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -17 -12 -16 Lock Lock Lock
     Growth % Lock Lock Lock Lock -294.7 28.4 -35.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 0 1 2 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -17 -12 -18 Lock Lock Lock
     Growth % Lock Lock Lock Lock -295.9 26.0 -45.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -17 -11 -14 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 1 0 0 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -17 -11 -14 Lock Lock Lock
     Growth % Lock Lock Lock Lock -320.5 35.1 -25.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -10 -11 -15 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 6 6 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -27 16 2 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 39 0 0 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -11 -11 -15 Lock Lock Lock
     Growth % Lock Lock Lock Lock -626.5 3.9 -35.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 36 20 7 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 44 33 19 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 1 1 1 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -34 -19 -6 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 3 3 2 Lock Lock Lock
Equity $m Lock Lock Lock Lock 41 31 17 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 42 31 17 Lock Lock Lock
     Growth % Lock Lock Lock Lock 200.3 -24.6 -44.7 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -39.1 -33.7 -73.6 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -42.2 -36.4 -83.3 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -60.0 -33.7 -72.9 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -61.6 -30.4 -57.2 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -34.5 -29.3 -61.1 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Leverage
Interest Cover X Lock Lock Lock Lock -789.7 -204.7 -517.8 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 2.1 1.6 0.4 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -84.1 -62.8 -37.7 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 18.4 14.9 7.3 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 18.4 14.9 7.3 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 93.9 86.1 63.1 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -465.6 -673.2 -951.0 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -39.1 -33.7 -73.6 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.1 1.1 1.1 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -42.2 -36.4 -83.3 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -42.2 -36.4 -83.3 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 814.6 229.1 40.5 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock -814.6 -229.1 -40.5 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

AYA Shortsell

Frequently Asked Questions

The current share price of Artrya Limited (AYA:ASX) is AU$0.68.
The 52-week high share price for Artrya Limited (AYA:ASX) is AU$1.04.
The 52-week low share price for Artrya Limited (AYA:ASX)? is AU$0.20.
Artrya Limited (AYA:ASX) does not pay a dividend.
Artrya Limited (AYA:ASX) does not pay a dividend.
Artrya Limited (AYA:ASX) has a franking level of 0.0%.
Artrya Limited (AYA:ASX) is classified in the Technology.
The current P/E ratio for Artrya Limited (AYA:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.